BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6565294)

  • 1. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differences in sensitivity to Augmentin (and other antibiotics) of Staphylococcus aureus strains isolated from various specimens and patients from different clinics].
    Ruczkowska J; Dolna I
    Przegl Lek; 1990; 47(10):702-5. PubMed ID: 2089448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of augmentin in beta-lactamase producing bacteria.
    Agrawal SK; Goel MM; Misra AB
    Indian J Med Res; 1987 Sep; 86():298-300. PubMed ID: 3501408
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
    Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A
    J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of BRL 25.000 (amoxycillin plus clavulanic acid) against Enterobacteriaceae betalactamase producers (author's transl)].
    Roy C; Segura C; Tirado M; Fuster C; Foz A
    Med Clin (Barc); 1982 Mar 1-15; 78(5):189-95. PubMed ID: 6978982
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
    Cokça F; Altay G
    Mikrobiyol Bul; 1992 Oct; 26(4):333-7. PubMed ID: 1435363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ; Ibrahim ME; Gill KP
    Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
    [No Abstract]   [Full Text] [Related]  

  • 10. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 11. Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).
    Traub WH
    Chemotherapy; 1985; 31(2):119-23. PubMed ID: 3872778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentin: an in vitro study of bacterial sensitivities to a synergistic combination.
    Neville MA
    N Z Med J; 1982 Aug; 95(714):579-81. PubMed ID: 6982440
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
    Glupczynski Y; McGillavry G; Yourassowsky E
    Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitivity to augmentin and cephalosporines of some bacterial strains isolated from hospitalized patients.
    Debeleac L; Iancu A; Tudorache D; Iancu G
    Rom J Intern Med; 1995; 33(3-4):227-35. PubMed ID: 8646195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of augmentin against pathogenic bacteria and its comparison with other antibiotics.
    Perryman F; Johnson S; Qadri SM
    Chemotherapy; 1983; 29(2):111-5. PubMed ID: 6839863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity of Salmonella strains to Augmentin and new generation cephalosporins and aminoglycosides].
    Dolna I; Gościniak G; Ruczkowska J
    Przegl Epidemiol; 1989; 43(2):218-22. PubMed ID: 2682793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterobacter resistant to amoxycillin/clavulanate.
    Lancet; 1982 Oct; 2(8301):768-9. PubMed ID: 6125837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of an amoxicillin-clavulanic acid combination on the aerobic fecal flora in children].
    Borderon JC; Rastegar A; Rolland JC; Laugier J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):569-72. PubMed ID: 3937129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
    Semenitz E; Casey PA; Pfaller W; Gstraunthaler G
    Chemotherapy; 1983; 29(3):192-207. PubMed ID: 6347546
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of the amoxicillin-gentamicin combination in the presence of clavulanic acid on 8 strains of amoxicillin-resistant bacteria].
    Deforges L; Soussy CJ; Duval J
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):496-500. PubMed ID: 6379567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.